Skip Ribbon Commands
Skip to main content

United States

Report | Life Sciences Site Selection: Regional Nuances, Global Trends

Summary

After R&D, real estate costs are among the most significant expenses for life sciences companies, from highly technical laboratories to the sophisticated facilities necessary to manufacture drugs in compliance with FDA and other regulations. No wonder, then, that industry clusters — where life sciences facilities and resources are focused — are shifting worldwide in response to the patent cliff and other economic pressures.​

To access the report, simply complete the form.

Please fill out the form to access the report.
Trouble downloading? Please click the following link.